Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05183672

Improving Post-acute Stroke Follow-up Care by Adopting Telecare Consultations in a Nurse-led Clinic

Since 2017, Hong Kong has provided post-acute stroke services in clinics operated by stroke advanced practice nurses (APNs). Currently, the applicability of the clinics has been further limited by the emergence of the coronavirus (COVID-19) pandemic due to restrictions on visits to the clinics and tightened social distancing requirements. Telecare consultations may be a viable option for contributing more flexible, interactive, and cost-efficient care models to support stroke survivors over the longer run. The present study takes advantage of this opportunity by utilizing implementation science to simultaneously implement and evaluate a telecare model of care in a nurse-led post-acute stroke clinic.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Nervous System Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • confirmed diagnosis of stroke within 1 month before enrolment, will be discharged home within a week, aged 18 or above, cognitively competent with a score equal to or greater than 22 in the Montreal Cognitive Assessment Hong Kong version, own a smartphone

Exclusion criteria

  • have unaccompanied hearing or vision loss, cannot be reached by phone, bedbound, have no Internet connection at home, participating in other clinical trials at the same time, require physical contact, i.e. wound dressing

Treatment and study plan

telecare consultation

Procedure

Using Zoom to communicate with patients

Usual face-to-face consultation

Procedure

Face-to-face communication with patients

Primary outcomes

  1. Chang in Degree of disability after stroke

    Time frame: baseline, three months when the program is completed, three months after the program is completed.

    Simplified modified Rankin scale will be used to measure the degree of disability for stroke patients. The scale has three questions to identify whether the patient has a score from 0 to 5, with higher scores representing higher degree of disability.

Secondary outcomes

  1. Incidence of the recurrence of stroke

    Time frame: baseline, three months when the program is completed, three months after the program is completed.

    The percentage of participants who re-admitted to hospital because of recurrent stroke

  2. Change of Quality of life, which measures an individual perception oftheir position in life. It includes physical and mental health.

    Time frame: baseline, three months when the program is completed, three months after the program is completed.

    Quality of life will be measured using the Hong Kong version of EuroQol 5-dimension. The scale has five subdomains, which include mobility, self-care, usual activities, pain and discomfort, and anxiety and depression. Since the scale has 5 items, each digit in the five digit codes refers to the status of each dimension, ranging from 1 for no problem, to 5 for sever problem. A higher scores indicate better quality of life.

  3. Change of Post-stroke depression

    Time frame: baseline, three months when the program is completed, three months after the program is completed.

    Post-stroke depression will be measured using the Chinese version of the Geriatric Depression scale. This scale has a minimum score of 0 and a maximum score of 15. Lower scores represent lower depression level.

  4. Change of Medication adherence

    Time frame: baseline, three months when the program is completed, three months after the program is completed.

    Medication adherence will be determined using the Adherence to Refills and Medications Scale. The scale produces an overall adherence score of 10-40, with lower scores indicating better adherence.

  5. Change of Social participation

    Time frame: baseline, three months when the program is completed, three months after the program is completed.

    Social participation will be measured using the 11-item Reintegration to Normal Living index. This scale is used to measure whether the patient has participated in several social activities before and after occurrence of stroke. The scale yields total score from 0-22, with higher scores indicating poorer social participation.

  6. Number of attendances at a general practitioners' office, emergency department, hospital, and general out-patient clinic

    Time frame: baseline, three months when the program is completed, three months after the program is completed.

    To measure the utilization of healthcare services by stroke patient before and after the intervention

Other outcomes

  1. Cost effectiveness of the program

    Time frame: baseline, three months when the program is completed, three months after the program is completed.

    Cost and quality-adjusted life years will be collected at baseline, three months when the program is completed, and three months after the program is completed. Incremental cost-effectiveness ratios between the groups will be calculated by dividing the difference in cost by the difference in quality-adjusted life years.

Study contacts

Contact information is provided by the study sponsor or research team.

Arkers Wong, Ph.D.

CONTACT

[email protected]

85234003805

Sponsors and collaborators

Lead sponsor

The Hong Kong Polytechnic University

Other

Collaborators

  • The Queen Elizabeth Hospital

Registry information

Official study title

Improving Post-acute Stroke Follow-up Care by Adopting Telecare Consultations in a Nurse-led Clinic During COVID-19 and Beyond: A Hybrid Type 2 Implementation-effectiveness Randomized Trial

Important dates

Study start
2022
Primary completion
2025
Study completion
2025
First posted
Jan 10, 2022
Registry last updated
Sep 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.